MedPath

Respiratory and Hemodynamic Targets During General Anesthesia

Not Applicable
Active, not recruiting
Conditions
Patients Undergoing General Anesthesia
Interventions
Procedure: Fraction of inspired oxygen
Procedure: Positive end expiratory pressure
Procedure: Blood pressure
Procedure: Tidal volume
Registration Number
NCT06047119
Lead Sponsor
Lars Wiuff Andersen
Brief Summary

This trial is an investigator-initiated, multicenter, randomized, factorial, single-blind trial of multiple hemodynamic and respiratory targets during general anesthesia. These targets include blood pressure, positive end expiratory pressure, tidal volume, and fraction of inspired oxygen. Patients will be randomized to different targets using a factorial design, i.e., each patient is simultaneously randomized to four interventions. There will be five enrolling sites in the Central Denmark Region. 480 high-risk patients will be enrolled.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
480
Inclusion Criteria
  • Age ≥ 18 years
  • American Society of Anesthesiologists (ASA) classification 3 to 5
  • Planned endotracheal intubation with positive pressure ventilation
  • Expected operating time ≥ 90 minutes
  • Certain types of surgery
Exclusion Criteria
  • Inability to obtain consent (e.g., patient is unconscious, hyperacute surgery)
  • Known or suspected pregnancy
  • Out-patient/same-day surgery
  • Intubated prior to surgery
  • Clinical judgement by the anesthesiologist that any of the interventions could be potentially harmful to the patient

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Fraction of inspired oxygen 80% during general anesthesia and 2 hours afterFraction of inspired oxygen-
Positive end expiratory pressure 10 cm H20 during general anesthesiaPositive end expiratory pressure-
Mean arterial blood pressure above 80 mmHg during general anesthesia and 2 hours afterBlood pressure-
Tidal volume 10 ml/kg during general anesthesiaTidal volume-
Mean arterial blood pressure above 60 mmHg during general anesthesia and 2 hours afterBlood pressure-
Positive end expiratory pressure 5 cm H20 during general anesthesiaPositive end expiratory pressure-
Tidal volume 5 ml/kg during general anesthesiaTidal volume-
Mean arterial blood pressure above 70 mmHg during general anesthesia and 2 hours afterBlood pressure-
Systolic blood pressure above 90% of baseline during general anesthesia and 2 hours afterBlood pressure-
Positive end expiratory pressure 8 cm H20 during general anesthesiaPositive end expiratory pressure-
Tidal volume 8 ml/kg during general anesthesiaTidal volume-
Fraction of inspired oxygen 30% during general anesthesia and 2 hours afterFraction of inspired oxygen-
Primary Outcome Measures
NameTimeMethod
Feasibility: Proportion of eligible patients randomizedUp to 90 days

Eligible patients will be defined as those meeting all inclusion criteria and none of the exclusion criteria 1 to 4.

Feasibility: Proportion of patient with adherence to the assigned interventionsDuring surgery

Adherence will be defined as follows:

The allocated positive end expiratory pressure (± 1 cm H2O), tidal volume (± 1 ml/kg), and FiO2 (± 5%) is used in a minimum of 90% of the randomized patients for the duration of the surgery.

Vasopressors/inotropes are only initiated and continued if the blood pressure declines below the allocated target in at least 60% of the patients and at least 60% of time during general anesthesia, i.e., 60% of the registered blood pressures should be within +/- 10 mmHg of the target when vasopressor/inotropes are administered.

Feasibility: Proportion of patients with separation of mean arterial pressureDuring surgery

We aim to achieve at least 5 mmHg separation in mean/median mean arterial pressure for the three blood pressure groups targeting mean arterial pressure.

Feasibility: Proportion of patients lost to follow-upUp to 90 days

We aim to obtain data from more than 90% of patients still alive at 30- and 90-days follow-up.

Secondary Outcome Measures
NameTimeMethod
Proportion of patient with acute kidney injury30 days

Composite of post-operative renal complications using Kidney Disease Improving Global Outcomes (KDIGO) criteria

CreatinineThe day after the surgery

Measured in umol/L

Proportion of patients with pulmonary post-operative complications (composite)30 days

A composite of the following based on European Perioperative Clinical Outcome definitions: Respirator infection, respirator failure, pleural effusion, atelectasis, pneumothorax, bronchospasms, and aspiration pneumonitis.

Proportion of patient with pneumonia30 days

Based on the United States of America Centers for Disease Control and Prevention (CDC) definition of pneumonia

Proportion of patient with pulmonary embolism30 days

Presence of pulmonary embolus on computerized tomography (CT) or magnetic resonance (MR) imaging, or a high probability of pulmonary embolus based on ventilation perfusion scan.

Proportion of patient with major adverse cardiac events30 days

A composite of the following based on European Perioperative Clinical Outcome definitions: Non-fatal cardiac arrest, acute myocardial infarction, congestive heart failure, new cardiac arrhythmia, and angina.

Troponin-IThe day after the surgery

Measured in ng/L

Proportion of patients with myocardial injury after non-cardiac surgery3 days

Post-operative troponin-I above the 99% percentile for the respective assay.

Alanine transaminaseThe day after the surgery

Measured in U/L

Proportion of patients with emergence delirium2 hours after the surgery

Based on the nursing delirium screening scale to evaluate emergence delirium 90-120 minutes after admission to the post-aesthesia care unit.

Opioid administered24 hours

Total opioid administered using morphine equivalent units.

Proportion of patients with surgical site infections30 days

Based on the United States of America Centers for Disease Control and Prevention (CDC) definition.

Proportion of patients with who die90 days
Health related quality of life90 days

Based on the EQ-5D-5L questionnaire

Proportion of patients with post-operative delirium7 days

We will categorize delirium as delirium if this is either stated in the medical journal or retrospectively categorized as delirium if it meets pre-defined criteria based on the diagnostic and statistical manual of mental disorders, fifth edition from the American psychiatric association

Post-operative pain2 hours after the surgery

Highest numeric rating scale (NRS) score (from 0 to 10 with higher scores indicating worse pain) documented

Quality of recovery90 days

Based on the quality of recovery-15 (QoR-15) score. The score ranges from 0-150 with higher scores indicating better recovery.

Proportion of patients with post-operative nausea and vomiting2 hours after the surgery

Highest numeric rating scale (NRS) score (from 0 to 10 with higher scores indicating worse nausea and vomiting) documented

Antiemetic treatment24 hours

Administered antiemetic treatment (ondansetron, dexamethasone, cyclizine, droperidol, metoclopramide) within the first 24 hours after the operation.

Length of hospital stayUp to 90 days

Reported in days.

Days alive and out of the hospitalWithin 30 days

Reported in days. Patients that die during the 30 days, will receive a value of 0. All admissions at acute care hospitals in Denmark will be included in this outcome.

Proportion of patients with intraoperative complicationsDuring surgery

Specific complications occurring during the surgery: Bleeding, need of blood product transfusions, arrhythmia, pneumothorax, cardiac arrest, mortality.

Clavien-Dindo grading of complications30 days

In addition to reporting the individual post-operative complications, we will use the validated Clavien-Dindo classification to grade post-operative complications by the interventions needed.

Proportion of patients with intensive care unit admission30 days

Both planned and unplanned stays at the intensive care unit.

Trial Locations

Locations (6)

Aarhus University Hospital

🇩🇰

Aarhus, Denmark

Horsens Regional Hospital

🇩🇰

Horsens, Denmark

Randers Regional Hospital

🇩🇰

Randers, Denmark

Viborg Regional Hospital

🇩🇰

Viborg, Denmark

Aalborg University Hospital

🇩🇰

Aalborg, Denmark

Gødstrup Regional Hospital

🇩🇰

Gødstrup, Denmark

© Copyright 2025. All Rights Reserved by MedPath